Pasar al contenido principal

DECODING A VIRUS ACHILLES HEEL: THE AFRICAN SWINE FEVER VIRUS INTERACTOME

PCI2021-121939

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Afrontar las Prioridades de Nuestro Entorno
Subprograma Subprograma Estatal de Internacionalización
Convocatoria Proyectos Programación Conjunta Internacional
Año convocatoria 2021
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New insights into the role of endosomal proteins for African swine fever virus infection

  • Cuesta-Geijo, Miguel Ángel
  • García-Dorival, Isabel
  • Puerto, Ana del
  • Urquiza, Jesús
  • Galindo Barreales, Inmaculada
  • Barrado-Gil, Lucía
  • Lasala, Fátima
  • Cayuela, Ana
  • Sorzano, Carlos Óscar S.
  • Gil, Carmen
  • Delgado, Rafael
  • Alonso Martí, Covadonga
28 p.-7 fig.-- Departamento de Biotecnología., African swine fever virus (ASFV) infectious cycle starts with the viral adsorption and entry into the host cell. Then, the virus is internalized via clathrin/dynamin mediated endocytosis and macropinocytosis. Similar to other viruses, ASF virion is then internalized and incorporated into the endocytic pathway. While the endosomal maturation entails luminal acidification, the decrease in pH acts on the multilayer structure of the virion dissolving the outer capsid. Upon decapsidation, the inner viral membrane is exposed to interact with the limiting membrane of the late endosome for fusion. Viral fusion is then necessary for the egress of incoming virions from endosomes into the cytoplasm, however this remains an intriguing and yet essential process for infection, specifically for the egress of viral nucleic acid into the cytoplasm for replication. ASFV proteins E248R and E199L, located at the exposed inner viral membrane, might be implicated in the fusion step. An interaction between these viral proteins and cellular endosomal proteins such as the Niemann-Pick C type 1 (NPC1) and lysosomal membrane proteins (Lamp-1 and -2) was shown. Furthermore, the silencing of these proteins impaired ASFV infection. It was also observed that NPC1 knock-out cells using CRISPR jeopardized ASFV infection and that the progression and endosomal exit of viral cores was arrested within endosomes at viral entry. These results suggest that the interactions of ASFV proteins with some endosomal proteins might be important for the membrane fusion step. In addition to this, reductions on ASFV infectivity and replication in NPC1 KO cells were accompanied by fewer and smaller viral factories. Our findings pave the way to understanding the role of proteins of the endosomal membrane in ASFV infection., This research was partially supported through the following awards: “La Caixa” Banking Foundation award number LCF/PR/HR19/52160012, Spain, https://fundacionlacaixa.org/en/ to CA and RD, Spanish Ministry of Science and Innovation, Spain RTI2018-097305-R- I00, https://www.ciencia.gob.es/ to CA, Instituto de Investigación Carlos III, ISCIII, Spain FIS PI 1801007, https://www.isciii.es/ to RD, European Commission, Horizon 2020 Framework Programme European Union ASFVInt ERANET-2021-862605 to CA, co-funded by Spanish Ministry of Science and Innovation, Spain PCI2021-121939 https://www.ciencia.gob.es/ to CA, VIRUSCAN FETPROACT-2016- 731868 and EPIC-CROWN-2-2021-101046084 https://ec.europa.eu/ to RD., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

N′-phenylacetohydrazide derivatives as potent Ebola virus entry inhibitors with an improved pharmacokinetic profile

  • García-Rubia, Alfonso
  • Lasala, Fátima
  • Ginex, Tiziana
  • Morales-Tenorio, Marcos
  • Olal, Catherine
  • Heung, Michelle
  • Oquist Phillips, Mayra Paola
  • Galindo Barreales, Inmaculada
  • Cuesta-Geijo, Miguel Ángel
  • Casasnovas, José María
  • Campillo, Nuria E.
  • Canales, Ángeles
  • Alonso Martí, Covadonga
  • Martínez Gil, Ana
  • Muñoz-Fontela, César
  • Delgado, Rafael
  • Gil, Carmen
19 p.-6 fig.-7 tab.-1 graph. abst., Ebola virus (EBOV) is a single-strand RNA virus belonging to the Filoviridae family, which has been associated to most Ebola virus disease outbreaks to date, including the West African and the North Kivu epidemics between 2013 and 2022. This unprecedented health emergency prompted the search for effective medical countermeasures. Following up on the carbazole hit identified in our previous studies, we synthetized a new series of compounds, which demonstrated to prevent EBOV infection in cells by acting as virus entry inhibitors. The in vitro inhibitory activity was evaluated through the screening against surrogate models based on viral pseudotypes and further confirmed using replicative EBOV. Docking and molecular dynamics simulations joined to saturation transfer difference–nuclear magnetic resonance (STD–NMR) and mutagenesis experiments to elucidate the biological target of the most potent compounds. Finally, in vitro metabolic stability and in vivo pharmacokinetic studies were performed to confirm their therapeutic potential., The project leading to these results has received funding from “la Caixa” Foundation under the project code LCF/PR/HR19/52160012. This research was partially supported through ERA-NET-2021-862605. Cofounded by AEI, Spain (PCI2021-121939 (C.A.), PID2019-105237GB-I00 (A.C.), PID2021-122825OB (C.A.), and PID2021-122223OB-I00 (C.G.)), Instituto de Salud Carlos III (CIBERINFEC and FIS PI2100989), and the European Commission Horizon 2020 Framework Programme (Project VIRUSCAN FETPROACT-2016: 731868 and Project EPIC-CROWN-2 ID: 101046084). This research work was also funded by the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). M.M.-T holds a predoctoral FPU grant (FPU18/03493) from MICINN, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of a Potential Entry-Fusion Complex Based on Sequence Homology of African Swine Fever and Vaccinia Virus

  • Urquiza, Jesús
  • Cuesta-Geijo, Miguel Ángel
  • García-Dorival, Isabel
  • Fernández, Óscar
  • Puerto, Ana del
  • Díaz, José Fernando
  • Alonso Martí, Covadonga
African swine fever virus (ASFV) belongs to the family of Asfarviridae, part of the group of nucleocytoplasmic large DNA viruses (NCLDV). Little is known about the internalization of ASFV in the host cell and the fusion membrane events that take place at early stages of the infection. Poxviruses, also members of the NCLDV and represented by vaccinia virus (VACV), are large, enveloped, double-stranded DNA viruses. Poxviruses were considered unique in having an elaborate entry-fusion complex (EFC) composed of 11 highly conserved proteins integrated into the membrane of mature virions. Recent advances in methodological techniques have again revealed several connections between VACV EFC proteins. In this study, we explored the possibility of an analogous ASFV EFC by identifying ten candidate proteins exhibiting structural similarities with VACV EFC proteins. This could reveal key functions of these ASFV proteins, drawing attention to shared features between the two virus families, suggesting the potential existence of an ASFV entry-fusion complex., This research was partially funded by the European Commission Horizon 2020 Framework Programme, European Union ASFVInt grant agreement 862605, cofunded by the Ministry of Science and Innovation, Agencia Estatal de Investigación, Spain PCI2021-121939/AEI/10.13039/501100011033; the Ministerio de Ciencia e Innovación Spain grant PID2021-122825OB; and the “La Caixa” Banking Foundation LCF/PR/HR19/52160012, Spain. O.F. was supported by European Commission-NextGenerationsEU (Regulation EU 2020/2094 through the CSIC Global Health Platform PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Insights into the function of ESCRT complex and LBPA in ASFV infection

  • Barrado-Gil, Lucía
  • García-Dorival, Isabel
  • Galindo Barreales, Inmaculada
  • Alonso Martí, Covadonga
  • Cuesta-Geijo, Miguel Ángel
13 Pág., The African swine fever virus (ASFV) is strongly dependent on an intact endocytic pathway and a certain cellular membrane remodeling for infection, possibly regulated by the endosomal sorting complexes required for transport (ESCRT). The ESCRT machinery is mainly involved in the coordination of membrane dynamics; hence, several viruses exploit this complex and its accessory proteins VPS4 and ALIX for their own benefit. In this work, we found that shRNA-mediated knockdown of VPS4A decreased ASFV replication and viral titers, and this silencing resulted in an enhanced expression of ESCRT-0 component HRS. ASFV infection slightly increased HRS expression but not under VPS4A depletion conditions. Interestingly, VPS4A silencing did not have an impact on ALIX expression, which was significantly overexpressed upon ASFV infection. Further analysis revealed that ALIX silencing impaired ASFV infection at late stages of the viral cycle, including replication and viral production. In addition to ESCRT, the accessory protein ALIX is involved in endosomal membrane dynamics in a lysobisphosphatydic acid (LBPA) and Ca2+-dependent manner, which is relevant for intraluminal vesicle (ILV) biogenesis and endosomal homeostasis. Moreover, LBPA interacts with NPC2 and/or ALIX to regulate cellular cholesterol traffic, and would affect ASFV infection. Thus, we show that LBPA blocking impacted ASFV infection at both early and late infection, suggesting a function for this unconventional phospholipid in the ASFV viral cycle. Here, we found for the first time that silencing of VPS4A and ALIX affects the infection later on, and blocking LBPA function reduces ASFV infectivity at early and later stages of the viral cycle, while ALIX was overexpressed upon infection. These data suggested the relevance of ESCRT-related proteins in ASFV infection., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was partially supported through the European Commission, Horizon 2020 Framework Programme European Union ASFVInt ERANET-2021-0017 co-funded by Spanish Ministry of Science and Innovation PCI2021-121939/AEI/10.13039/501100011033 (https://www.ciencia.gob.es/); “La Caixa” Banking Foundation award number LCF/PR/HR19/52160012, Spain; and the Spanish Ministry of Science and Innovation, Spain PID2021-122825OB. This research work was also funded by the European Commission−NextGenerationEU (Regulation EU 2020/ 2094), through CSIC’s Global Health Platform (PTI SaludGlobal)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Overview of modern commercial kits for laboratory diagnosis of African swine fever and swine influenza A viruses

  • Muzykina, Larysa
  • Barrado-Gil, Lucía
  • González De Bulnes, Antonio
  • Crespo-Piazuelo, Daniel
  • Cerón, José Joaquín
  • Alonso Martí, Covadonga
  • Montoya, María
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., Rapid and early detection of infectious diseases in pigs is important, especially for the implementation of control measures in suspected cases of African swine fever (ASF), as an effective and safe vaccine is not yet available in most of the affected countries. Additionally, analysis for swine influenza is of significance due to its high morbidity rate (up to 100%) despite a lower mortality rate compared to ASF. The wide distribution of swine influenza A virus (SwIAV) across various countries, the emergence of constantly new recombinant strains, and the danger of human infection underscore the need for rapid and accurate diagnosis. Several diagnostic approaches and commercial methods should be applied depending on the scenario, type of sample and the objective of the studies being implemented. At the early diagnosis of an outbreak, virus genome detection using a variety of PCR assays proves to be the most sensitive and specific technique. As the disease evolves, serology gains diagnostic value, as specific antibodies appear later in the course of the disease (after 7–10 days post-infection (DPI) for ASF and between 10–21 DPI for SwIAV). The ongoing development of commercial kits with enhanced sensitivity and specificity is evident. This review aims to analyse recent advances and current commercial kits utilised for the diagnosis of ASF and SwIAV., LM is a fellow funded by project grants for funding for displaced Ukrainian scientists from CSIC and ALLEA (EFDS-FL1-34). This work was supported by grants CPP2021-008618 funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR; by the Spanish Ministry of Science and Innovation grant PID2021-122825OB and the European Commission, Horizon 2020 Framework Programme European Union ASFVInt ERANET-2021-0017 co-funded by Spanish Ministry of Science and Innovation PCI2021-121939/AEI/10.13039/501100011033 (https://www.ciencia.gob.es/, accessed on 1 March 2024)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparative Proteomics and Interactome Analysis of the SARS-CoV-2 Nucleocapsid Protein in Human and Bat Cell Lines

  • Armstrong, Stuart D.
  • Alonso Martí, Covadonga
  • García-Dorival, Isabel
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 and responsible for the global coronavirus pandemic which started in 2019. Despite exhaustive efforts to trace its origins, including potential links with pangolins and bats, the precise origins of the virus remain unclear. Bats have been recognized as natural hosts for various coronaviruses, including the Middle East respiratory coronavirus (MERS-CoV) and the SARS-CoV. This study presents a comparative analysis of the SARS-CoV-2 nucleocapsid protein (N) interactome in human and bat cell lines. We identified approximately 168 cellular proteins as interacting partners of SARS-CoV-2 N in human cells and 196 cellular proteins as interacting partners with this protein in bat cells. The results highlight pathways and events that are both common and unique to either bat or human cells. Understanding these interactions is crucial to comprehend the reasons behind the remarkable resilience of bats to viral infections. This study provides a foundation for a deeper understanding of host–virus interactions in different reservoirs, This work was funded by the U.S. Food and Drug Administration Medical Countermeasures Initiative contract (75F40120C00085). The work was also funded by the UK MRC-funded G2P2-UK (MR/Y004205/1). This research was partially funded by the European Commission Horizon 2020 Framework Programme, European Union ASFVInt grant agreement 862605, co-funded by the Ministry of Science and Innovation, Agencia Estatal de Investigación, Spain, PCI2021-121939/AEI/10.13039/501100011033; the Ministerio de Ciencia e innovación Spain grant PID2021-122825OB; and Fundación La Caixa Health Research LCF/PR/HR19/52160012. I.G.-D. was supported by the Atracción de Talento Investigador grant NO 2020-T2/BIO-19948, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery of thiophene derivatives as potent, orally bioavailable, and blood–brain barrier-permeable Ebola virus entry inhibitors

  • Morales-Tenorio, Marcos
  • Lasala, Fátima
  • García-Rubia, Alfonso
  • Aledavood, Elnaz
  • Heung, Michelle
  • Olal, Catherine
  • Escudero-Pérez, Beatriz
  • Alonso Martí, Covadonga
  • Martínez Gil, Ana
  • Muñoz-Fontela, César
  • Delgado, Rafael
  • Gil, Carmen
22 p.-7 fig.-7 tab.-5 schem.-1 graph. abst., The endemic nature of the Ebola virus disease in Africa underscores the need for prophylactic and therapeutic drugs that are affordable and easy to administer. Through a phenotypic screening employing viral pseudotypes and our in-house chemical library, we identified a promising hit featuring a thiophene scaffold, exhibiting antiviral activity in the micromolar range. Following up on this thiophene hit, a new series of compounds that retain the five-membered heterocyclic scaffold while modifying several substituents was synthesized. Initial screening using a pseudotype viral system and validation assays employing authentic Ebola virus demonstrated the potential of this new chemical class as viral entry inhibitors. Subsequent investigations elucidated the mechanism of action through site-directed mutagenesis. Furthermore, we conducted studies to assess the pharmacokinetic profile of selected compounds to confirm its pharmacological and therapeutic potential., The project leading to these results has received funding from “la Caixa” Foundation under the project code LCF/PR/HR19/52160012. This research was partially supported through ERA-NET-2021-862605. Cofounded by AEI, Spain (PCI2021-121939 (C.A.), PID2021-122825OB (C.A.), and PID2021-122223OB-I00 (C.G.)), Instituto de Salud Carlos III (CIBERINFEC, CIBERNED, and FIS PI2100989), and the European Commission Horizon 2020 Framework Programme (Project VIRUSCAN FETPROACT-2016: 731868 and Project EPIC-CROWN-2 ID: 101046084). This research work was also funded by the European Commission–NextGenerationEU (Regulation EU 2020/2094) through CSIC’s Global Health Platform (PTI Salud Global). M.M.-T. holds a predoctoral FPU grant (FPU18/03493) from MICINN., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

From diarylsulfides to diarylamines: new Ebola virus entry inhibitors with improved metabolic stability

  • Morales-Tenorio, Marcos
  • Lasala, Fátima
  • García-Rubia, Alfonso
  • Aledavood, Elnaz
  • Heung, Michelle
  • Olal, Catherine
  • Escudero-Pérez, Beatriz
  • Oquist, Paola
  • Canales, Ángeles
  • Alonso Martí, Covadonga
  • Martínez Gil, Ana
  • Muñoz-Fontela, César
  • Delgado, Rafael
  • Gil, Carmen
15 p.-7 fig.-4 tab.-1 graph. abst., The persistence of current outbreaks of Ebola virus (EBOV) disease and challenges in the production and administration of approved vaccines and treatments highlight the continuous exploration of new therapeutic alternatives. In this context, this work focuses on optimizing diarylsulfide hits previously identified as EBOV entry inhibitors. Structural modifications resulted in diarylamine derivatives, with confirmed antiviral activity against replicative EBOV and significantly improved metabolic stability compared to diarylsulfides. Using different techniques, the EBOV glycoprotein (EBOV-GP) was identified as the target of these compounds. Residue Y517GP2 is critical for biological activity, while T519GP2, E100GP1, and D522GP2 also contribute to ligand binding. Furthermore, the binding of the derivatives to EBOV-GP has been shown to destabilize the complex with the virus receptor NPC1. In short, a new family of diarylsulfides and diarylamines with antiviral activity against EBOV has been developed, and their mechanism of action has been deciphered, paving the way for future pharmaceutical development., The project leading to these results has received funding from “la Caixa” Foundation under the project code LCF/PR/HR19/52160012. This research was partially supported through ERA-NET-2021-862605 and cofounded by MICIU/AEI/10.13039/501100011033 and FEDER/UE (Grants PCI2021-121939 (C.A.), PID2021-122825OB (C.A.), PID2023-151109OB-I00 (A.C.) and PID2021-122223OB-I00 (C.G.)), Instituto de Salud Carlos III (CIBERINFEC, CIBERNED and FIS PI2100989), and the European Commission Project e-FabRIC: ID: 101137157, HORIZON-HLTH-2023-DISEASE-03-04 and Project Ebola PREP-TBOX, ID 101145709, and HORIZON-JU-GH-EDCTP3-2023-01 to RD. This research work was also funded by the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI+ Salud Global). M.M.-T. holds a predoctoral FPU grant (FPU18/03493) from MICINN., Peer reviewed